Intense FDG Uptake of Metastatic Clear Cell Carcinoma From the Ovary in a Uterine Leiomyoma

Uterine leiomyoma may cause slightly or moderately increased F-18 fluorodeoxyglucose (F-18 FDG) uptake in the low pelvis. However, severely intense FDG accumulation resulting from the disease is rare. We present a patient with uterine leiomyoma and metastatic clear cell carcinoma from the ovary, who...

Full description

Saved in:
Bibliographic Details
Published in:Clinical nuclear medicine 2006-07, Vol.31 (7), p.429-431
Main Authors: Cherng, Shiou-Chi, Liou, Chang-Hsien, Fan, Yu-Ming, Yuan, Yao-Nan, Chiu, Chuang-Shin
Format: Article
Language:English
Subjects:
Adenocarcinoma, Clear Cell - blood
Adenocarcinoma, Clear Cell - diagnostic imaging
Adenocarcinoma, Clear Cell - metabolism
Adenocarcinoma, Clear Cell - secondary
Antigens, Neoplasm - blood
Biomarkers, Tumor - blood
CA-125 Antigen - blood
Female
Fluorodeoxyglucose F18 - pharmacokinetics
Humans
Leiomyoma - diagnostic imaging
Middle Aged
Neoplasms, Multiple Primary - diagnostic imaging
Ovarian Neoplasms - blood
Ovarian Neoplasms - pathology
Positron-Emission Tomography
Radiopharmaceuticals - pharmacokinetics
Tomography, X-Ray Computed
Uterine Neoplasms - diagnostic imaging
Uterine Neoplasms - metabolism
Uterine Neoplasms - secondary
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Uterine leiomyoma may cause slightly or moderately increased F-18 fluorodeoxyglucose (F-18 FDG) uptake in the low pelvis. However, severely intense FDG accumulation resulting from the disease is rare. We present a patient with uterine leiomyoma and metastatic clear cell carcinoma from the ovary, whose F-18 FDG positron emission tomography/computed tomography (PET/CT) imaging revealed heterogeneous, slightly increased FDG uptake of the ovarian cancer, but homogeneous, greatly increased FDG uptake of the uterine leiomyoma lesions. These findings suggest that intense FDG uptake in a uterine leiomyoma may be combined with malignancy.
ISSN:0363-9762
1536-0229
DOI:10.1097/01.rlu.0000223141.38391.62